Note 8 — Pre-Funded Warrants

At June 30, 2026 and December 31, 2025, the Company had 3,410,086 and 653,827 pre-funded warrants outstanding, respectively, with an exercise price of $0.001 per share and no expiration date.

During the six months ended June 30, 2026, a warrant holder exercised 266,666 pre-funded warrants for exercise proceeds of $267 and a warrant holder exercised 631,332 pre-funded warrants on a cashless basis, receiving 631,192 shares of the Company’s common stock with 140 shares of the Company’s common stock forfeited to cover the exercise price.

At June 30, 2026, all pre-funded warrants were exercisable, although the pre-funded warrants may be exercised only to the extent that the total number of shares of common stock then beneficially owned by such warrant holder does not exceed 9.99% of the outstanding shares of the Company’s common stock immediately after giving such effect to such exercise.